Balancing cure and long-term risks in acute lymphoblastic leukemia

Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia - From the St. Jude Lifetime Cohort

(2014) Kerri A. Nottage et al.   BRITISH JOURNAL OF HAEMATOLOGY

Long-term decline in intelligence among adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation

(2013) K. R. Krull et al.   BLOOD

Neurocognitive Outcomes Decades After Treatment for Childhood Acute Lymphoblastic Leukemia: A Report From the St Jude Lifetime Cohort Study

(2013) Kevin R. Krull et al.   JOURNAL OF CLINICAL ONCOLOGY

Postinduction Dexamethasone and Individualized Dosing ofEscherichia ColiL-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01

(2013) Lynda M. Vrooman et al.   JOURNAL OF CLINICAL ONCOLOGY

Second Malignant Neoplasms After Treatment of Childhood Acute Lymphoblastic Leukemia

(2013) Kjeld Schmiegelow et al.   JOURNAL OF CLINICAL ONCOLOGY

Evaluation of Memory Impairment in Aging Adult Survivors of Childhood Acute Lymphoblastic Leukemia Treated With Cranial Radiotherapy

(2013) Gregory T. Armstrong et al.   JNCI-Journal of the National Cancer Institute

Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group

(2012) Stephen P. Hunger et al.   JOURNAL OF CLINICAL ONCOLOGY

Cognitive Outcomes Following Contemporary Treatment Without Cranial Irradiation for Childhood Acute Lymphoblastic Leukemia

(2012) H. M. Conklin et al.   JNCI-Journal of the National Cancer Institute

Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial

(2012) Leonard A Mattano et al.   LANCET ONCOLOGY

The use of liposomal anthracycline analogues for childhood malignancies: A systematic review

(2011) E. Sieswerda et al.   EUROPEAN JOURNAL OF CANCER

The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL Consortium

(2011) Lynda M. Vrooman et al.   EUROPEAN JOURNAL OF CANCER

Prospective Study on Incidence, Risk Factors, and Long-Term Outcome of Osteonecrosis in Pediatric Acute Lymphoblastic Leukemia

(2011) Mariël L. te Winkel et al.   JOURNAL OF CLINICAL ONCOLOGY

The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI

(2011) Christina Halsey et al.   Journal of Hematology & Oncology

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

(2010) V. Conter et al.   BLOOD

Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia

(2010) J. D. Kawedia et al.   BLOOD

Unusual Case of Extrapulmonary Metastatic Recurrence in a Patient With Osteosarcoma

(2010) Vivek S. Radhakrishnan et al.   JOURNAL OF CLINICAL ONCOLOGY

Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial

(2010) Steven E Lipshultz et al.   LANCET ONCOLOGY

Methotrexate/6-mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study

(2009) K. Schmiegelow et al.   BLOOD

Late Mortality Among 5-Year Survivors of Childhood Cancer: A Summary From the Childhood Cancer Survivor Study

(2009) Gregory T. Armstrong et al.   JOURNAL OF CLINICAL ONCOLOGY

Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997–2004)

(2009) Anjo J Veerman et al.   LANCET ONCOLOGY

Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000)

(2009) L B Silverman et al.   LEUKEMIA

Cerebrovascular disease in childhood cancer survivors: A Children's Oncology Group Report

(2009) B. Morris et al.   NEUROLOGY

Treating Childhood Acute Lymphoblastic Leukemia without Cranial Irradiation

(2009) Ching-Hon Pui et al.   NEW ENGLAND JOURNAL OF MEDICINE

Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study

(2008) R. Mody et al.   BLOOD